Teodora Karan-Djurašević

Higher-order connections between stereotyped subsets: implications for improved patient classification in CLL

Andreas Agathangelidis, Anastasia Chatzidimitriou, Katerina Gemenetzi et al. · Blood · 2020 · 123 citations · Full text

Association of Bax Expression and Bcl2/Bax Ratio with Clinical and Molecular Prognostic Markers in Chronic Lymphocytic Leukemia

Ksenija Vučićević, Vladimir Jakovljević, Nataša Čolović et al. · Journal of Medical Biochemistry · 2016 · 75 citations · Full text

Gene Mutation Profiles in Primary Diffuse Large B Cell Lymphoma of Central Nervous System: Next Generation Sequencing Analyses

Milena Todorović, Jelena Jelicic, Biljana Mihaljević et al. · International Journal of Molecular Sciences · 2016 · 36 citations · Full text

Genetics, Dlbcl Cns, Pathology +16

Chronic Lymphocytic Leukemia with Mutated IGHV4-34 Receptors: Shared and Distinct Immunogenetic Features and Clinical Outcomes

Aliki Xochelli, Panagiotis Baliakas, Ioannis Kavakiotis et al. · Clinical Cancer Research · 2017 · 33 citations

Use of Wilms Tumor 1 Gene Expression as a Reliable Marker for Prognosis and Minimal Residual Disease Monitoring in Acute Myeloid Leukemia With Normal Karyotype Patients

Irena Marjanović, Teodora Karan-Djurašević, Milena Ugrin et al. · Clinical Lymphoma Myeloma & Leukemia · 2017 · 32 citations

Hematological Malignancy, Tumor Biology, Oncology +14